Substance active (DCI)
- crisantaspase recombinante
Informations techniques
Exploitant
JAZZ PHARMACEUTICALS
Présentation
ENRYLAZE 10 mg/0,5 mL, solution injectable / pour perfusion
3 flacons en verre de 0,5 ml (CIP : 34009 550 986 8 3)
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
JLFb6LRSU4WyEQm7
